The Mesothelioma Center News – Page 15
-
Research & Clinical TrialsOne of the biggest obstacles to treating pleural mesothelioma cancer effectively is its often late-stage diagnosis. A recent study shows encouraging signs that…
-
Research & Clinical Trials
Mesothelioma Clinical Trial Studies Keytruda, Lenvatinib Combination
A possible second-line treatment for pleural mesothelioma may be on the horizon after a phase II clinical trial showed impressive efficacy with early… -
Legislation & Litigation
Johnson & Johnson Ends Worldwide Sale of Talc-Based Baby Powder
Against the wishes of its shareholders, Johnson & Johnson announced Aug. 11 that it would end the worldwide sale of talc-based Johnson’s Baby Powder… -
Veterans & Military
Camp Lejeune Veterans Win Justice
On Wednesday, Aug. 10, President Joe Biden signed the comprehensive Honoring Our PACT Act of 2022 into law, allowing military veterans and families harmed… -
Research & Clinical Trials
Study Suggests Relationship Between Stromal Tumors and Mesothelioma
Early identification of peritoneal mesothelioma cancer – when it is most effectively treated – may become more common after a recent study revealed a… -
Asbestos Exposure & Bans
WHO Reclassifies Firefighting as High-Risk Occupation for Cancer
The World Health Organization has reclassified firefighting to its highest level of occupational risk for cancer after extensive research confirmed an alarming level of… -
Treatment & Doctors
UK Approves Opdivo/Yervoy Immunotherapy for Pleural Mesothelioma
Patients with unresectable pleural mesothelioma cancer throughout the United Kingdom will now have the immunotherapy combination of Opdivo and Yervoy as an option… -
Asbestos Exposure & Bans
Study: Those Exposed to Asbestos Should Not Take Beta-Carotene
Taking beta-carotene health supplements could increase the risk of lung cancer or death from cardiovascular disease for anyone who is regularly exposed to asbestos,… -
Treatment & Doctors
MARF to Host International Symposium on Malignant Mesothelioma
Leading medical specialists will gather with mesothelioma patients, families, friends and advocates at the much-anticipated 2022 International Symposium on Malignant Mesothelioma, July 23, in… -
Asbestos Exposure & Bans
New Study Underscores Importance of Worldwide Asbestos Ban
The push for a worldwide ban on asbestos gained momentum recently with the latest study linking national consumption levels of the toxic mineral with…